Woodstock, GA – May 2, 2011 – NeoMed announces that it has obtained CE Mark approval for its NeoMed Oral/Enteral Syringes and Dispensers. The CE Mark approval is a significant accomplishment that validates the quality of NeoMed products. NeoMed’s full line of Oral/Enteral Syringes and Dispensers will soon be available throughout Europe in both sterile and non-sterile packaging. This is a significant expansion from the current distribution in the United States and Canada. NeoMed is excited to expand its offerings globally to protect patients through safe administration practices with Oral/Enteral Syringes and Dispensers.
Tony Lair CEO & President of NeoMed, Inc. commented:
“Expanding our product line into Europe is another key milestone for NeoMed to become a leading manufacturer of enteral safety devices. We strive to provide superior products to clinicians to help promote the importance of enteral safety and to help mitigate risks to patients.”
NeoMed Oral/Enteral Syringes and Dispensers are designed to mitigate misconnection errors with enteral only, non-threaded connections that protect the patient while providing the highest level of care. Offered in 1ml, 3ml, 6ml, 12ml, 20ml, 35ml and 60ml sizes, these Oral/Enteral Syringes and Dispensers also feature precise pump compatibility, a self-righting tip cap, and are designed to meet the most rigorous compliance standards.